Clicky

Polynovo Ltd  (PNV)

Description: PolyNovo Limited is a medical device company. The Company designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. The Company focuses on medical devices that are used in the treatment of burns, surgical wounds and negative pressure wound therapy (NPWT). It is involved in the development of NovoPore for use as a dressing in NPWT that involves a wound-contacting foam dressing, a sealing membrane, a suction pump, and a drainage tube from the dressing to a canister, and Biodegradable Temporising Matrix (BTM), a wound dressing focused on treatment of full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal, and requires a split-thickness skin graft for final closure. In addition, the Company is engaged in the development of breast sling prototypes for non-clinical and clinical trials, as well as new products for hernia and breast reconstructions.


Keywords: Medicine Construction Clinical Medicine Surgery Medical Device Medical Equipment Pump Clinical Trial Wound Plastic Surgery Burns Drainage Medical Dressings Prototypes Pressure Ulcer Hernia Breast Reconstruction Negative Pressure Wound Therapy Novo Sorb

Home Page: polynovo.com

PNV Technical Analysis

Putnam Investment Funds
,

Phone: 61 3 8681 4050


Officers

Name Title
Mr. Jan-Marcel Gielen C.A. CFO & Company Sec.
Dr. David McQuillan Ph.D. Chief Technical & Scientific Officer
Mr. Swami Raote BPHARM, M.B.A. CEO & Director
Mr. Ahmed Hassan Director of Operations
Ms. Teena Chadha APAC Marketing & Distributor Mang.
Ms. Monica Benyk HR Mang.
Dr. Tim Moore Principal Scientist
Mr. Edward Graubart Sr. VP of Sales & Marketing (Americas)

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 30.7692
Trailing PE: 0
Price-to-Book MRQ: 76.4859
Price-to-Sales TTM: 33.6394
IPO Date:
Fiscal Year End: June
Full Time Employees: 152
Back to stocks